Matrix metalloproteinases in tumor invasion

Cellular and Molecular Life Sciences

Volumn 57, Issue 1, 2000, Pages 5-15

  Johansson, N ^a   Ahonen, M ^b,c   Kahari V M ^b,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Invasion; Matrix; Metalloproteinase; Squamous cell carcinoma

Indexed keywords

COLLAGENASE; GELATINASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

CANCER INVASION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; PROTEIN DEGRADATION; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

ANIMALS; CELL MOVEMENT; COLLAGENASES; EXTRACELLULAR MATRIX; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0033982379     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050495     Document Type: Review

References (148)

1. 1 Birkedal-Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A. and Engler J. A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4: 197-250
2. 2 Kähäri V.-M. and Saarialho-Kere U. (1997) Matrix metalloproteinases in skin. Exp. Dermatol. 6: 199-213
3. 3 Shapiro S. D. (1998) Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10: 602-608
4. 4 Kähäri V.-M. and Saarialho-Kere U. (1999) Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann. Med. 31: 34-45
5. 5 Nagase H. and Woessner J. F. (1999) Matrix metalloproteinases. J. Biol. Chem 274: 21491-21494
6. 6 Knäuper V., López-Otín C, Smith B., Knight G. and Murphy G. (1996) Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544-1550
7. 7 Mitchell P. G., Magna H, A., Reeves L. M., Lopresti Morrow L. L., Yocum S. A., Rosner P. J. et al. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97: 761-768
8. 8 Krane S. M., Byrne M. H., Lemaitre V., Henriet P., Jeffrey J. J., Witter J. P. et al. (1996) Different collagenase gene products have different roles in degradation of type I collagen. J. Biol. Chem. 271: 28509-28515
9. 9 Liu X, Wu H., Byrne M., Jeffrey J., Krane S. and Jaenisch R. (1995) A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130: 227-237
10. 10 Hasty K. A., Hibbs M. S., Kang A. H. and Mainardi C. L. (1986) Secreted forms of human neutrophil collagenase. J. Biol. Chem. 261: 5645-5650
11. 11 Hasty K. A., Pourmotabbed T. F., Goldberg G. I., Thompson J. P.. Spinella D. G., Stevens R. M. et al. (1990) Human neutrophil collagenase: a distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265: 11421-11424
12. 12 Cole A. A., Chubinskaya S., Schumacher B., Huch K., Szabo G., Yao J. et al. (1996) Chondrocyte matrix metalloproteinase-8: human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271: 11023-11026
13. 13 Hanemaaijer R., Sorsa T., Konttinen Y.T., Ding Y., Sutinen M., Visser H. et al. (1997) Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J. Biol. Chem 272: 31504-31509
14. 14 Shlopov B. V., Lie W. R., Mainardi C. L., Cole A. A., Chubinskaya S. and Hasty K. A. (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 40: 2065-2074
15. 15 Giambernardi T. A., Grant G. M., Taylor G. P., Hay R. J., Maher V. M., McCormick J. J. et al. (1998) Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16: 483-496
16. 16 Baibin M., Fueyo A., Knäuper V., Pendás A. M., López J. M., Jimenez M. G. et al. (1998) Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes: analysis of its potential role in postpartum involution of the uterus. J Biol. Chem 273: 23959-23968
17. 17 Freije J. M., Diez-Itza I., Baibín M., Sanchez L. M., Blasco R., Tolivia J. et al. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16773
18. 18 Knäuper V., Cowell S., Smith B., López-Otín C., O'Shea M., Morris H. et al. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem 272: 7016-7608
19. 19 Ashworth J. L., Murphy G., Rock M. J., Sherratt M. J., Shapiro S. D., Shultleworth C. A. et al. (1999) Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem. J. 340: 171-181
20. 20 Knäuper V., Will H., Lôpez-Otín C., Smith B., Atkinson S. J., Stanton H. et al. (1996) Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271: 17124-17131
21. 21 d'Ortho M. P., Will H., Atkinson S., Butler G., Messent A., Gavrilovic J. et al. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250: 751-757
22. 22 Johansson N., Saarialho-Kere U., Airola K., Herva R., Nissinen L., Westermarck J. et al. (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208: 387-397
23. 23 Ståhle-Bäckdahl M., Sandstedt B., Bruce K., Lindahl A., Jimenez M., Vega J. et al. (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76: 717-728
24. 24 Lindy O., Konttinen Y. T., Sorsa T., Ding Y., Santavirta S., Ceponis A. et al. (1997) Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 40: 1391-1399
25. 25 Moldovan F., Pelletier J. P., Hambor J., Cloutiera J. M. and Martel-Pelletier J. (1997) Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor-β. Arthritis Rheum. 40: 1653-1661
26. 26 Tetlow L. C. and Woolley D. E. (1998) Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br. J. Rheumatol. 37: 64-70
27. 27 Vaalamo M., Mattila L., Johansson N., Kariniemi A.-L., Karjalainen-Lindsberg M.-L., Kähäri V.-M. et al. (1997) Distinct populations of stromal cells express collagenase-3 (MMP-13) and coilagenase-1(MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109: 96-101
28. 28 Vaalamo M., Karjalainen-Lindsberg M.-L., Puolakkainen P., Kere J. and Saarialho-Kere U. K. (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage melalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am. J. Pathol. 152: 1005-1014
29. 29 Uitto V.-J., Airola K., Vaalamo M., Johansson N., Putnins E. E., Firth J. D. et al. (1998) Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am. J. Pathol. 152: 1489-1499
30. 30 Sukhova G. K., Schonbeck U., Rabkin E., Schoen F. J., Poole A. R., Billinghurts R. C. et al. (1999) Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99: 2503-2509
31. 31 Mao D, Lee J. K., VanVickle S. J. and Thompson R. W. (1999) Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem. Biophys. Res. Commun. 261: 904-910
32. 32 Heppner K. J., Matrisian L. M., Jensen R. A. and Rodgers W. H. (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149: 273-282
33. 33 Uría J. A., Ståhle-Bäckdahl M., Seiki M., Fueyo A. and Lôpez-Otín C. (1997) Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res. 57: 4882-4888
34. 34 Johansson N., Airola K., Grénman R., Kariniemi A.-L., Saarialho-Kere U. and Kähäri V.-M. (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 151: 499-508
35. 35 Airola K., Johansson N., Kariniemi A.-L., Kähäri V.-M., and Saarialho-Kere U. (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Invest. Dermatol. 109: 225-231
36. 36 Cazorla M., Hernandez L., Nadal A., Balbin M., Lopez J. M., Vizoso F. et al. (1998) Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J. Pathol. 186: 144-150
37. 37 Johansson N., Vaalamo M., Grenman S., Hietanen S., Klemi P., Saarialho-Kere U. et al. (1999) Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am. J. Pathol 154: 469-480
38. 38 Uría J. A., Balbin M., López J. M., Alvarez J., Vizoso F., Takigawa M. et al. (1998) Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am. J. Pathol 153: 91-101
39. 39 Airola K., Karonen T., Vaalamo M., Lehti K., Lohi J., Kariniemi A.-L. et al. (1999) Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer 80: 733-743
40. 40 Chandler S., Miller K. M., Clements J. M., Lury J., Corkill D., Anthony D. C. et al. (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72: 155-161
41. 41 Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I. B., Enghild J. J. et al. (1996) Degradation of interleukin-1β by matrix metalloproteinases. J. Biol. Chem. 271: 14657-14660
42. 42 Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M. et al. (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704
43. 43 Pei D., Majmudar G. and Weiss S. J. (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269: 25849-25855
44. 44 Saarialho-Kere U. K., Croucha E. C. and Parks W. C. (1995) Matrix metalloproteinase malrilysin is constitutively expressed in adult human exocrine epithelium. J. Invest. Dermatol. 105: 190-196
45. 45 Dunsmore S. E., Saarialho-Kere U. K., Roby J. D., Wilson C. L., Matrisian L. M., Welgus H. G. et al. (1998) Matrilysin expression and function in airway epithelium. J. Clin. Invest. 102: 1321-1331
46. 46 Karelina T. V., Goldber G. I. and Eisen A. Z. (1994) Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J. Invest. Dermatol. 103: 482-487
47. 47 Wilson C. L. and Matrisian L. M. (1996) Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 28: 123-136
48. 48 Bredow D. C. von, Nagel R. B., Bowden G. T. and Cress A. E. (1997) Cleavage of β4 integrin by matrilysin. Exp. Cell Res. 236: 341-345
49. 49 Shapiro S. D., Kobayashi D. K. and Ley T. J. (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268: 23824-23829
50. 50 Vaalamo M., Kariniemi A.-L., Shapiro S. D. and Saarialho-Kere U. (1999) Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J. Invest. Dermatol. 112: 499-505
51. 51 Chandler S., Cossin J., Lury J. and Wells G. (1996) Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumor necrosis factor-α fusion protein. Biochem. Biophys. Res. Commun. 228: 421-429
52. 52 Aimes R. T. and Quigiey J. P. (1995) Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J. Biol. Chem. 270: 5872-5876
53. 53 Okada Y., Nara K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N. et al. (1995) Localization of matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72: 311-322
54. 54 Butler G. S., Butler M. J., Atkinson S. J., Will H., Tamura T., Westreum S. S. van et al. (1998) The TIMP-2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. J. Biol. Chem 273: 871-880
55. 55 Zucker S., Drews M., Conner C., Foda H. D., DeClerck Y. A., Langley K. E. et al. (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J. Biol. Chem. 273: 1216-1222
56. 56 Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E. et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 615-616
57. 57 Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M. and Okada Y. (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macro-molecules. J. Biol. Chem. 272: 2446-2451
58. 58 Okada A., Bellocq J. P., Rouyer N., Chenard M. P., Rio M. C., Chambon P. et al. (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92: 2730-2734
59. 59 Sato T., Carmen Ovejero M. del, Hou P., Heegaard A. M., Kumegawa M., Foged N. T. et al. (1997) Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J. Cell Sci. 110: 589-596
60. 60 Takino T., Sato H., Shinagawa A. and Seiki M. (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270: 23013-23020
61. 61 Will H. and Hinzmann B. (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231: 602-608
62. 62 Matsumoto S., Katoh M., Saito S., Watanabe T. and Masuho Y. (1997) Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim. Biophys. Acta 1354: 159-170
63. 63 Shofuda K. I., Yasumitsu H., Nishihashi A., Miki K. and Miyazaki K. (1997) Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. J. Biol. Chem. 272: 9749-9754
64. 64 Puente X. S., Pendás A. M., Llano E., Velasco G. and López-Otín C. (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56: 944-949
65. 65 Llano E, Pendas A.M., Freije J.P., Nakano A., Knäuper V., Murphy G. et al. (1999) Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. Cancer Res 59: 2570-2576
66. 66 Pei D. (1999) Identification and characterization of the fifth membrane-type matrix metalloproteianse MT5-MMP. J. Biol. Chem 274: 8932-8952
67. 67 Cossins J., Dudgeon T. J., Catlin G., Gearing A. J. and Clements J. M. (1996) Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228: 494-498
68. 68 Pendás A. M., Knäuper V., Puente X. S., Llano E., Mattei M. G., Apte S. et al. (1997) Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J. Biol. Chem. 272: 4281-4286
69. 69 Llano E., Pendás A. M., Knäuper V., Sorsa T., Salo T., Salido E. et al. (1997) Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101-15108
70. 70 Velasco G, Pendas A. M., Fueyo A., Knäuper V., Murphy G. and López-Otín C. (1999) Cloning and characterization of human MMP-23, a new matrix metalloproteinase pre-dominantly expressed in reproductive tissues and lacking conserved domains in other family members. J. Biol. Chem. 274: 4570-4576
71. 71 Ståhle-Bäckdahl M. and Parks W. C. (1993) 92-kD gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am. J. Pathol. 142: 995-1000
72. 72 Westermarck J. and Kähäri V.-M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13: 781-792
73. 73 Karin M., Liu Z. G. and Zandi E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246
74. 74 Wasylyk C., Gutman A., Nicholson R. and Wasylyk B. (1991) The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10: 1127-1134
75. 75 Westermarck J., Seth A. and Kähäri V.-M. (1997) Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14: 2651-2660
76. 76 Wernert N., Raes M. B., Lassalle P., Dehouck M. P., Gosselin B., Vandenbunder B. et al. (1992) c-ets 1 protooncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140: 119-127
77. 77 Wernert N., Gilles F., Fafeur V., Bouali F., Raes M. B., Pyke C. et al. (1994) Stromal expression of c-Etsl transcrip-tion factor correlates with tumor invasion. Cancer Res. 54: 5683-5688
78. 78 Bond M., Fabunmi R. P., Baker A. H. and Newby A. C. (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-K B. FEBS Lett. 435: 29-34
79. 79 Lohi J., Lehti K., Westermarck J., Kähäri V.-M. and Keski-Oja J. (1996) Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem. 239: 239-247
80. 80 Cowley S., Paterson H., Kemp P. and Marshall C. J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PCI2 differentiation and for transformation of NIH-3T3 cells. Cell 77: 841-852
81. 81 Mansour S. J., Matten W. T., Hermann A. S., Candia J. M., Rong S., Fukasawa K. et al. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970
82. 82 Oka H., Chatani Y., Hoshino R., Ogawa O., Kakehi Y., Terachi T. et al. (1995) Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 55: 4182-4187
83. 83 Sivaraman V. S., Wang H., Nuovo G. J. and Malbon C. C. (1997) Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99: 1478-1483
84. 84 Gum R., Wang H., Lengyel E., Juarez J. and Boyd D. (1997) Regulation of 92 kDa type IV collagenase expression of the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493
85. 85 Reunanen N., Westermarck J., Häkkinen L., Holmström T. H., Elo I., Eriksson J. E. et al. (1998) Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273: 5137-5145
86. 86 Simon C., Goepfert H. and Boyd D. (1998) Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced M, 92,000 type IV collagenasc secretion and in vitro invasion. Cancer Res. 58: 1135-1139
87. 87 Westermarck J., Holmström T. H., Ahonen M., Eriksson J. E. and Kähäri V.-M. (1998) Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by Jun N-terminal kinase and p38 stress-activated protein kinase. Matrix Biol. 17: 547-557
88. 88 Ravanti L., Heino J., López-Otín C. and Kähäri V.-M. (1999) Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activaled protein kinase. J. Biol. Chem. 274: 2446-2455
89. 89 Johansson N. R. Ala-aho, Uitto V.-J., Grénman R., Fusenig N. E., López-Otín C. et al. (2000). Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J. Cell Sci. (in press)
90. 90 Nagase H. (1997) Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160
91. 91 Wart H. E. van and Birkedal-Hansen H. (1990) The cystein switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87: 5578-5582
92. 92 Pei D. and Weiss S. J. (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247
93. 93 Sato H., Kinoshita T., Takino T., Nakayama K. and Seiki M. (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393: 101-104
94. 94 Douglas D. A., Shi Y. E. and Sang Q. A. (1997) Computational sequence analysis of tissue inhibitor of metalloproteinase family. J. Prol. Chem. 16: 237-255
95. 95 Gomez D. E., Alonso D. F., Yoshiji H. and Thorgeirsson U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122
96. 96 Apte S. S., Olsen B. R. and Murphy G. (1995) The gene structure of tissue inhibitor of metalloprotcinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270: 14313-14318
97. 97 Greene J., Wang M., Liu Y. E., Raymond L. A., Rosen C. and Shi Y. E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380
98. 98 Leco K. J., Khokha R., Pavloff N., Hawkes S. P. and Edwards D. R. (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360
99. 99 Mattila L., Airola K., Ahonen M., Hietarinta M., Black C., Saarialho-Kere U. et al. (1998) Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J. Invest. Dermatol. 110: 416-421
100. 100 Vaalamo M., Leivo T. and Saarialho-Kere U. (1999) Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum. Pathol. 30: 795-802
101. 101 Dollery C. M., McEwan J. R., Wang M., Sang Q. A., Liu Y. E. and Shi Y. E. (1999) TIMP-4 is regulated by vascular injury in rats. Circ. Res. 84: 498-504
102. 102 Kauppila S., Saarela J., Slenbäck F., Risteli J., Kauppila A. and Risteli L. (1996) Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. Am. J. Pathol. 148: 539-548
103. 103 Stetler-Stevenson W. G., Aznavoorian S. and Liotla L. A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9: 541-573
104. 104 Murray G. I., Duncan M. E., O'Neil P., McKay J. A., Melvin W. T. and Fothergill J. E. (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185: 256-261
105. 105 Murray G. I., Duncan M. E., O'Neil P., McKay J. A., Meivin W. T. and Fothergill J. E. (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185: 256-261
106. 106 Shima I., Sasapuri Y., Kusukawa J., Fujita H., Kakegava T. and Morimatsu M. (1992) Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma: a clinicopathological study. Cancer 70: 2747-2753
107. 107 Muller D., Wolf C., Abecassis J., Millon R., Engelmann A., Bronner G. et al. (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res. 53: 165-169
108. 108 Davidson B., Goldberg I., Kopolovic J., Lerner-Geva L., Gotlieb W. H., Ben-Baruch G. et al. (1999) MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol. Oncol. 73: 372-382
109. 109 Johansson N., Westermarck J., Leppä S., Häkkinen L., Koivisto L., López-Otín C. et al. (1997) Collagenase-3 (matrix metalloproteinase-13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor-α and transforming growth factor-β. Cell Growth Differ. 8: 243-250
110. 110 Talvensaari-Mattila A., Apaja-Sarkkinen M., Höyhtyä M., Westerlund A., Puistola U. and Turpeenniemi-Hujanen T. (1999) Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation. Gynecol. Oncol. 72: 306-311
111. 111 Wilson C. L., Heppner K. J., Labosky P. A., Hogan B. L. and Matrisian L. M. (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA 94: 1402-1407
112. 112 Masson R., Lefebreve O., Noel A., El Fahime M., Chenared M.-P., Wendung C. et al. (1998) In vivo evidence that stromelysin-3 metalloproteinase contributes in a paracrine manner in epithelial cell malignancies. J. Cell Biol. 140: 1535-1541
113. 113 Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H. and Itohara S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58: 1048-1051
114. 114 Brown, P. D. 1998. Synthetic inhibitors of matrix metalloproteinases. In: Matrix Metalloproteinases, pp. 243-262, Mecham R., Parks W. C. (eds), Academic Press, San Diego
115. 115 Basset P., Okada A., Chenard M. P., Kannan R., Stoll I., Anglard P. et al. (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 15: 535-541
116. 116 Guo H., Zucker S., Gordon M. K., Toole B. P. and Biswas C. (1997) Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem. 272: 24-27
117. 117 Yoshizaki T., Sato T., Maruyama Y., Murono S., Furukawa M., Park C. S. el al. (1997) Increased expression of membrane type-1 metalloproteinase in head and neck carcinoma. Cancer 79: 139-144
118. 118 Dong Z., Kumar R., Yang X. and Fidler I. J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88: 801-810
119. 119 Patterson B. C. and Sang Q. A. (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B, type IV collagenase (MMP-9). J. Biol. Chem. 272: 28823-28825
120. 120 Lijnen H. R., Ugwu F., Bini A. and Collen D. (1998) Generation of an angiostatin-like fragment from plasminogen by siromelysin-1 (MMP-3). Biochemistry 37: 4699-4702
121. 121 Visschcr D. W., Höyhtyä M., Ottosen S. K., Liang C. M., Sarkar F. H., Crissman J. D. et al. (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer 59: 339-344
122. 122 Yoshiji H., Gomez D. E. and Thorgeirsson U. P. (1996) Enhanced RNA expression of tissue inhibitor of melalloproteinases-1 (TIMP-1) in human breast cancer. Int. J. Cancer 69: 131-134
123. 123 Nuovo G. J., MacDonnell P. B., Simsir A., Valea F. and French D. L. (1995) Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55: 267-275
124. 124 Wagner S. N., Ockenfels H. M., Wagner C., Soyer H. P. and Goos M. (1996) Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas. J. Invest. Dermatol. 106: 321-326
125. 125 Airola K., Ahonen M., Johansson N., Heikkilä P., Kere J., Kähäri V.-M. et al. (1998) Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J. Histochem. Cytochem. 46: 437-447
126. 126 Sutinen M., Kainulainen T., Hurskainen T., Vesterlund E., Alexander J. P., Overall C. M. et al. (1998) Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br. J. Cancer 77: 2239-2245
127. 127 Polette M., Clavel C., Muller D., Abecassis J., Binninger I. and Birembaut P. (1991) Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 11: 76-83
128. 128 Albini A., Melchiori A., Santi L., Liotta L. A., Brown P. D. and Stetler-Stevenson W. G. (1991) Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst. 83: 775-779
129. 129 Declerck Y. A., Yean T. D., Chan D., Shimada H. and Langley K. E. (1991) Inhibition of tumor invasion of smooth-muscle cell layers by recombinant human melalloproteinase inhibitor. Cancer Res. 51: 2151-2157
130. 130 Tsuchiya Y., Sato H., Endo Y., Okada Y., Mai M., Sasaki T. et al. (1993) Tissue inhibitor of metalloproteinase-1 is a negative regulator of the metastatic abilily of a human gastric-cancer cell-line, Kkls, in the chick-embryo. Cancer Res. 53: 1397-1402
131. 131 Matsuzawa K., Fukuyama K., Hubbard S. L., Dirks P. B. and Rutka J. T. (1996) Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential. J. Neuropathol. Exp. Neurol. 55: 88-96
132. 132 Watanabe M., Takahashi Y., Ohta T., Mai M., Sasaki T. and Seiki M. (1996) Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer 77: 1676-1680
133. 133 Alonso D. F., Skilton G., DeLorenzo M. S., Scursoni A. M., Yoshiji H. and Gomez D. E. (1998) Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1. Oncol Rep. 5: 1083-1087
134. 134 Martin D. C., Ruther U., Sanchez-Sweatman O. H., Orr F. W. and Khokha R. (1996) Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene 13: 569-576
135. 135 Kruger A., Sanchez-Sweatman O. H., Martin D. C., Fata J. E., Ho A. T., Orr F. W. et al. (1998) Host TIMP-1 overexprcssion confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene 16: 2419-2423
136. 136 Montgomery A. M., Mueller B. M., Reisfeld R. A., Taylor S. M. and DeClerck Y. A. (1994) Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res. 54: 5467-5473
137. 137 Oku T., Ata N., Yonezawa K., Tokai H., Fujii H., Shinagawa A., Ohuchi E. and Saiki I. (1997) Antimetastatic and antitumor effect of a recombinant human tissue inhibitor of metalloproteinases-2 in murine melanoma models. Biol. Pharm. Bull. 20: 843-849
138. 138 Koop S., Khokha R., Schimdt H. E., MacDonald I. C., Morris V. L., Chambers A. F. et al. (1994) Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54: 4791-4797
139. 139 Wang M., Liu Y. E., Greene J., Sheng S., Fuchs A., Rosen E. M. et al. (1997) Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogcne 14: 2767-2774
140. 140 Valente P., Fassina G., Melchiori A., Masiello L., Cilli M., Vacca A. et al. (1998) TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75: 246-253
141. 141 Guedez L., Courtemanch L. and Stetler-Stevenson M. (1998) Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptolic phenotype in germinal center B cells. Blood 92: 1342-1349
142. 142 Ahonen M., Baker A. H. and Kähäri V.-M. (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58: 2310-2315
143. 143 Baker A. H., Zaltsman A. B., George S. J. and Newby A. C. (1998) Divergent effects of tissue inhibitor of metalloproteinase-1, -2 or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro: TIMP-3 promotes apoptosis. J. Clin. Invest. 101: 1478-1487
144. 144 Baker A. H., George S. J., Zaltsman A. B., Murphy G. and Newby A. C. (1999) Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br. J. Cancer 79: 1347-1355
145. 145 Bian J., Wang Y., Smith M. R., Kim H., Jacobs C., Jackman J. et al. (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17: 1805-1811
146. 146 Smith M. R., Kung H. F., Durum S. K., Colburn N. H. and Sun Y. (1997) TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells. Cytokine 9: 770-780
147. 147 Kayagaki N., Kawasaki A., Ebata T., Ohmoto H., Ikeda S., Inoue S. et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182: 1777-1783
148. 148 Amour A., Slocombe P. M., Webster A., Butler M., Knight C. G., Smith B. J. et al. (1998) TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435: 39-44